S T A T E O F N E W Y O R K
________________________________________________________________________
9217
2025-2026 Regular Sessions
I N A S S E M B L Y
November 3, 2025
___________
Introduced by M. of A. PAULIN -- read once and referred to the Committee
on Codes
AN ACT to amend the penal law, in relation to excluding certain medica-
tion from being deemed unlawful to prescribe or dispense; and to amend
the education law, in relation to excluding certain medication from
being deemed misbranded
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Subdivision 3 of section 178.00 of the penal law, as added
by chapter 81 of the laws of 1995, is amended to read as follows:
3. (A) "Criminal diversion act" means an act or acts in which a person
knowingly:
[(a)] (I) transfers or delivers, in exchange for anything of pecuniary
value, a prescription medication or device with knowledge or reasonable
grounds to know that the recipient has no medical need for it; or
[(b)] (II) receives, in exchange for anything of pecuniary value, a
prescription medication or device with knowledge or reasonable grounds
to know that the seller or transferor is not authorized by law to sell
or transfer such prescription medication or device; or
[(c)] (III) transfers or delivers a prescription in exchange for
anything of pecuniary value; or
[(d)] (IV) receives a prescription in exchange for anything of pecuni-
ary value.
(B) THE PRESCRIBING, DISPENSING, OR RECEIPT OF BRAND NAME OR GENERIC
MIFEPRISTONE OR ANY DRUG USED FOR MEDICATION ABORTION SHALL NOT BE
CONSIDERED A CRIMINAL DIVERSION ACT FOR PURPOSES OF THIS DEFINITION
SOLELY BECAUSE IT IS NO LONGER APPROVED BY THE FEDERAL FOOD AND DRUG
ADMINISTRATION OR BECAUSE IT NO LONGER BEARS THE LABEL CURRENTLY IN
EFFECT, PROVIDED THAT:
(I) ITS LABELING WAS TRUE AND ACCURATE AT THE TIME OF MANUFACTURE; AND
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD13908-02-5
A. 9217 2
(II) THE DRUG IS RECOMMENDED FOR THE PURPOSE FOR WHICH IT WAS
PRESCRIBED UNDER WORLD HEALTH ORGANIZATION GUIDELINES THAT ARE CURRENT
AT THE TIME OF PRESCRIBING OR DISPENSING.
§ 2. Subdivision 13 of section 6802 of the education law, as added by
chapter 987 of the laws of 1971, is amended to read as follows:
13. "Misbranding". A. If a drug, device or cosmetic is alleged to be
misbranded because the labeling is misleading, or if an advertisement is
alleged to be false because it is misleading then in determining whether
the labeling or advertisement is misleading there shall be taken into
account (among other things) not only representations made or suggested
by statement, word, design, device, sound or any combination thereof,
but also the extent to which the labeling fails to reveal facts material
in the light of such representations or material with respect to conse-
quences which may result from the use of the drug, device, or cosmetic
to which the labeling or advertising relates under the conditions of use
prescribed in the labeling or advertising thereof or under such condi-
tions of use as are customary or usual.
B. No drug, device or cosmetic which is subject to, and complies with
regulations promulgated under the provisions of the federal food, drug,
and cosmetic act, relating to adulteration and misbranding shall be
deemed to be adulterated or misbranded in violation of the provisions of
this article because of its failure to comply with the board's regu-
lations, or the rules of the state board of pharmacy, insofar as the
regulations are in conflict with regulations relating to adulteration
and misbranding under the federal food, drug and cosmetic act.
C. NOTWITHSTANDING PARAGRAPH B OF THIS SUBDIVISION, BRAND NAME OR
GENERIC MIFEPRISTONE OR ANY DRUG USED FOR MEDICATION ABORTION SHALL NOT
BE DEEMED TO BE ADULTERATED OR MISBRANDED IN VIOLATION OF THE PROVISIONS
OF THIS ARTICLE SOLELY BECAUSE IT IS NO LONGER APPROVED OR NO LONGER
BEARS THE LABEL CURRENTLY IN EFFECT, PROVIDED THAT (1) ITS LABELING WAS
TRUE AND ACCURATE AT THE TIME OF MANUFACTURE; AND (2) THE DRUG IS RECOM-
MENDED FOR THE PURPOSE FOR WHICH IT WAS PRESCRIBED UNDER WORLD HEALTH
ORGANIZATION GUIDELINES THAT ARE CURRENT AT THE TIME OF PRESCRIBING OR
DISPENSING.
§ 3. Section 6815 of the education law is amended by adding a new
subdivision 3 to read as follows:
3. DRUGS USED FOR MEDICATION ABORTION. BRAND NAME OR GENERIC MIFEPRI-
STONE OR ANY DRUG USED FOR MEDICATION ABORTION SHALL NOT BE DEEMED AN
ADULTERATED OR MISBRANDED DRUG IN VIOLATION OF THE PROVISIONS OF THIS
ARTICLE SOLELY BECAUSE IT IS NO LONGER APPROVED OR NO LONGER BEARS THE
LABEL CURRENTLY IN EFFECT, PROVIDED THAT:
A. ITS LABELING WAS TRUE AND ACCURATE AT THE TIME OF MANUFACTURE; AND
B. THE DRUG IS RECOMMENDED FOR THE PURPOSE FOR WHICH IT WAS PRESCRIBED
UNDER WORLD HEALTH ORGANIZATION GUIDELINES THAT ARE CURRENT AT THE TIME
OF PRESCRIBING OR DISPENSING.
§ 4. Severability. If any item, clause, sentence, subparagraph, subdi-
vision, section or other part of this act, or the application thereof to
any person or circumstances shall be held to be invalid, such holding
shall not affect, impair or invalidate the remainder of this act, or the
application of such section or part of a section held invalid, to any
other person or circumstances, but shall be confined in its operation to
the item, clause, sentence, subparagraph, subdivision, section or other
part of this act directly involved in such holding, or to the person and
circumstances therein involved.
§ 5. This act shall take effect immediately.